American Century Companies Inc. lifted its position in Medidata Solutions Inc (NASDAQ:MDSO) by 6.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,592,367 shares of the company’s stock after buying an additional 97,571 shares during the period. American Century Companies Inc. owned about 2.60% of Medidata Solutions worth $116,736,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MDSO. Dimensional Fund Advisors LP boosted its stake in shares of Medidata Solutions by 0.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 130,588 shares of the company’s stock worth $8,202,000 after buying an additional 663 shares during the last quarter. Oregon Public Employees Retirement Fund raised its holdings in Medidata Solutions by 3.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 22,786 shares of the company’s stock valued at $1,836,000 after acquiring an additional 666 shares during the period. Front Row Advisors LLC raised its holdings in Medidata Solutions by 6.1% in the 2nd quarter. Front Row Advisors LLC now owns 12,623 shares of the company’s stock valued at $980,000 after acquiring an additional 725 shares during the period. Polen Capital Management LLC raised its holdings in Medidata Solutions by 12.2% in the 2nd quarter. Polen Capital Management LLC now owns 7,413 shares of the company’s stock valued at $597,000 after acquiring an additional 806 shares during the period. Finally, Metropolitan Life Insurance Co. NY raised its holdings in Medidata Solutions by 3.0% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 34,464 shares of the company’s stock valued at $2,776,000 after acquiring an additional 993 shares during the period.
In other news, EVP Michael I. Otner sold 7,030 shares of the firm’s stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the transaction, the executive vice president now directly owns 62,548 shares of the company’s stock, valued at $4,340,831.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.70% of the stock is currently owned by company insiders.
Several research analysts have weighed in on the stock. Royal Bank of Canada set a $86.00 price target on shares of Medidata Solutions and gave the company a “buy” rating in a report on Friday, October 19th. JPMorgan Chase & Co. cut shares of Medidata Solutions from an “overweight” rating to a “neutral” rating and set a $87.00 price target on the stock. in a report on Tuesday, July 24th. ValuEngine cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Tuesday, July 24th. Morgan Stanley set a $84.00 price target on shares of Medidata Solutions and gave the company a “hold” rating in a report on Wednesday, July 25th. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Tuesday, October 16th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the stock. Medidata Solutions presently has an average rating of “Buy” and an average price target of $84.64.
Shares of MDSO opened at $72.21 on Friday. Medidata Solutions Inc has a 12 month low of $59.60 and a 12 month high of $88.87. The company has a market cap of $4.44 billion, a PE ratio of 84.95, a price-to-earnings-growth ratio of 4.28 and a beta of 1.30. The company has a current ratio of 2.52, a quick ratio of 2.52 and a debt-to-equity ratio of 0.15.
Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Thursday, October 18th. The company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The company had revenue of $163.41 million for the quarter, compared to analysts’ expectations of $162.09 million. During the same period last year, the firm earned $0.33 earnings per share. The business’s revenue for the quarter was up 17.6% on a year-over-year basis. As a group, equities analysts predict that Medidata Solutions Inc will post 0.85 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Medidata Solutions Inc (MDSO) Position Increased by American Century Companies Inc.” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/11/10/medidata-solutions-inc-mdso-position-increased-by-american-century-companies-inc.html.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Featured Article: How accurate is the Rule of 72?
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.